Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(18 sites)

United States

UC San Francisco Medical Center, San Francisco, California

Childrens National Hospital, Washington D.C., District of Columbia

Washington Univ School Of Medicine, St Louis, Missouri

Austria

Novartis Investigative Site, Vienna

China

Novartis Investigative Site, Beijing, Beijing Municipality

Germany

Novartis Investigative Site, Frankfurt am Main, Hesse

Greece

Novartis Investigative Site, Ioannina

Novartis Investigative Site, Thessaloniki

Malaysia

Novartis Investigative Site, Kota Bharu, Kelantan

Netherlands

Novartis Investigative Site, Amsterdam, North Holland

South Africa

Novartis Investigative Site, Bloemfontein, Free State

Taiwan

Novartis Investigative Site, Taichung

Novartis Investigative Site, Taipei

Turkey (Türkiye)

Novartis Investigative Site, Adana, Saricam

Novartis Investigative Site, Ankara, Yenimahalle

Novartis Investigative Site, Izmir

United Kingdom

Novartis Investigative Site, Southampton